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Background: AtCRY2 forms photobodies in plants.
Results: AtCRY2 forms photobodies in human cells. By fusing AtCRY2 to a human checkpoint protein, the DNA damage
response can be activated by light.
Conclusion: AtCRY2 and its fusion proteins can achieve light-induced protein multimerization independent of other plant
proteins.
Significance: AtCRY2 can function as an optogenetic tool to modulate signaling pathways.
Nuclear bodies are discrete suborganelle structures that per-
form specialized functions in eukaryotic cells. In plant cells,
light can induce de novo formation of nuclear bodies called pho-
tobodies (PBs) composed of the photosensory pigments, phyto-
chrome (PHY) or cryptochrome (CRY). Themechanisms of for-
mation, the exact compositions, and the functions of plant PBs
are not known. Here, we have expressed Arabidopsis CRY2
(AtCRY2) in mammalian cells and analyzed its fate after blue
light exposure to understand the requirements for PB forma-
tion, the functions of PBs, and their potential use in cell biology.
We found that light efficiently inducesAtCRY2-PB formation in
mammalian cells, indicating that, other than AtCRY2, no plant-
specific proteins or nucleic acids are required for AtCRY2-PB
formation. Irradiation of AtCRY2 led to its degradation; how-
ever, degradation was not dependent upon photobody forma-
tion. Furthermore, we found thatAtCRY2photobody formation
is associated with light-stimulated interaction withmammalian
COP1 E3 ligase. Finally, we demonstrate that by fusing AtCRY2
to the TopBP1 DNA damage checkpoint protein, light-induced
AtCRY2 PBs can be used to activate DNA damage signaling
pathway in the absence of DNA damage.
Nuclear bodies (NBs)2 are nuclear structures similar to cyto-
plasmic organelles such as mitochondrion, Golgi organelles,
and lysosomes. NBs differ from cytoplasmic organelles in one
important aspect, in that although cytoplasmic organelles are
enclosed by a membrane and have, to a significant extent, a
relatively well defined composition, NBs are not encapsulated
by a membrane, and as a result, they have a more dynamic
composition that is influenced by intracellular as well as extra-
cellular milieu (1–3). In mammalian cells, the best known NBs
are nucleoli, Cajal bodies, and promyelocytic leukemia nuclear
bodies (PML-NBs). Nucleoli and Cajal bodies are involved in
ribosomal RNA and small nuclear RNA biosynthesis and pro-
cessing, respectively. PML-NBs are involved in maintenance of
genome stability under physiological conditions and in DNA
repair and apoptosis under conditions of genotoxic stress.
Plant cells have nuclear bodies as well, and upon light expo-
sure, plant proteins involved in photosensory functions form a
unique class of nuclear bodies with properties quite similar to
mammalian NBs (4–7). The plant NBs that are formed follow-
ing light exposure are referred to as photobodies (PBs) (4).
Amongplant photosensory proteins, the red light receptor phy-
tochromes (PHYs) are the most extensively studied with
respect to photobody formation. More recently, it has been
found that the blue light photosensory receptor cryptochrome
(CRY) forms photobodies as well (8, 9).
The compositions of PHY-PB andCRY-PB and the role of PB
formation in signaling by these photoreceptors are not known.
A genetic screen has identified several genes that are required
for PHY-PB formation, and one of these proteins, hemera, has
been found to associatewith PHY-PBs (10). CRY-PBs have been
analyzed mostly by using AtCRY2 (8, 9). Recent work suggests
that AtCRY2 controls signaling pathways by two mechanisms
(11). In one mechanism, AtCRY2 binds to a basic helix-loop-
helix family member, the CIB (cryptochrome-interacting basic
helix-loop-helix 1) transcription factor, upon excitation by blue
light and promotes transcription of cognate promoters (11). In
the second mechanism, AtCRY2 binds to the COP1 (constitu-
tively photomorphogenic 1) E3 ligase through a light-activated
and SPA1 (suppressor of phytochrome A) protein-mediated
mechanism, forming a ternary CRY2-SPA1-COP1 complex
and photobodies. Within photobodies, the E3 ligase activity of
COP1 on cognate transcription factors that mediate the blue
light response, such as flowering, is inhibited, which leads to
accumulation of these factors and up-regulation of blue light-
responsive genes (12–14). In addition, withinCRY2-PBs, COP1
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ubiquitylates AtCRY2, leading to its eventual proteolysis and
down-regulation of the blue light signaling pathway.
Humans have two CRY homologues (15, 16). Although both
exhibit a high degree of sequence similarity with Arabidopsis
CRYs, there is no convincing experimental evidence suggesting
that human CRYs, which function as core circadian clock pro-
teins, mediate any blue light sensory activity (15, 16). Hence, we
reasoned that human cells could be used to determine the
requirements for photobody formation by AtCRY2. We find
that blue light stimulates hCOP1-AtCRY2 binding in the
absence of SPA1 and leads to formation of CRY-PBs in which
AtCRY2 is subject to proteolysis. We conclude that
AtCRY2-PB formation does not depend on other plant proteins
or nucleic acids. Using AtCRY2-human checkpoint fusion pro-
teins, we demonstrate that we can regulate human DNA dam-
age checkpoint responses by sequestering and concentrating
the relevant proteins with blue light pulses.
EXPERIMENTAL PROCEDURES
Plasmid Construction—Plasmids used in this work can be
obtained from Addgene with detailed sequence information.
To generate pEGFP-N1-AtCRY2, AtCRY2 was amplified by
PCR and inserted into the pEGFP-N1 vector (Clontech). To
generate pEGFP-N1-mCRY2, mCRY2 was amplified by PCR
and inserted into the pEGFP-N1 vector. pEGFP-N1-DmCRY
was generated by subcloning the SpeI-XhoI fragment from
pFastBac-DmCRY (17) into the pEGFP-N1 vector. To generate
pmCherry-N1-mCOP1, mCOP1 was amplified by PCR and
inserted into the pmCherry-N1 (Clontech) vector. To generate
pcDNA3.1-AtCRY2-GFP-TopBP1, TopBP1 from LacR-Top-
BP1 (18) was amplified by PCR and cloned into the NotI/PmeI
sites of pcDNA3.1-AtCRY2-GFP plasmid. To generate pcDNA5/
FRT/TO-AtCRY2-EGFP, AtCRY2-EGFP fragment was ampli-
fied from pEGFP-N1-AtCRY2 by PCR. Then the PCR product
was inserted into the pcDNA5/FRT/TO vector (Invitrogen).
All plasmid sequences were verified by sequencing at the
GenomeAnalysis Facility at theUniversity of North Carolina at
Chapel Hill. Primer sequences used for PCR will be provided
upon request.
Cell Lines—HEK293T and FlpTM-In T-RExTM-293 cells
(Invitrogen) were maintained in Dulbecco’s minimal essential
medium supplemented with 10% fetal bovine serum and peni-
cillin-streptomycin. The Flp-In/FLAG-AtCRY2-EGFP cell line
was generated according to the manufacturer’s protocols
(Invitrogen).
Immunoprecipitation—Flp-in/FLAG-AtCRY2-EGFP cells were
treated with 0.5 g/ml tetracycline and continuously cultured in
the dark for 48h.Then the cellswere exposed to 366nmof light (1
milliwatt/cm2) and harvested at the indicated time points. Cells
were lysedwithPBS (phosphate-buffered saline) buffer containing
0.5% Triton X-100 and protease inhibitors (Roche Applied Sci-
ence) followed by two rounds of freeze-thaw cycles. Equal
amounts of protein were incubated with anti-FLAG M2-agarose
beads (Sigma) for 2 h at 4 °C. Beads were washed three times with
lysis buffer; bound proteins were eluted in 2 SDS-sample buffer
and analyzed by immunoblotting.
Fluorescence Microscopy—For GFP fluorescence micros-
copy, HEK293T cells were cultured on poly-D-lysine Cellware
12-mm round coverslips (BD Biosciences) placed in 35-mm
dishes. Cells were transfectedwith the indicated plasmids using
Lipofectamine 2000 reagent (Invitrogen). After a 24-h incuba-
tion at 37 °C, cells were exposed to 366 nmof light (2milliwatts/
cm2) from a Blak-Ray long wave UV lamp (UVP, LLC) for the
indicated time points. We obtained the same results with a
lamp emitting mainly at 470 nm (blue light), but we performed
most of our experiments with the Blak-Ray long wave UV lamp
emitting mainly at 366 nm, which we will refer to as blue light
for simplicity. The cells were washed twice with PBS, fixed
immediately with 3.7% methanol-free formaldehyde in PBS for
15 min, and washed twice with PBS. For GFP (FITC) and
mCherry fluorescence imaging, the cells were washed three
times and mounted in Prolong Gold antifade with DAPI
reagent.
For PML body immunofluorescence staining, cells were per-
meabilized by PBT (0.1% Triton X-100 in PBS) after fixation,
blocked with antibody blocking buffer (1% BSA in PBT) for 1 h,
and incubated with anti-PML (2 g/ml) antibody (Santa Cruz
Biotechnology) for 45min. Afterwashing three timeswith PBT,
the cells were incubated with Alexa Fluor 594 (1:500 dilution)
(goat anti-mouse IgG, Invitrogen) secondary antibody for 30
min. Then the coverslip was washed three times and mounted
in Prolong Gold antifade with DAPI reagent. Images were cap-
tured using a LeicaSP2 confocal microscope. The protein prox-
imity index was calculated by using the protein proximity ana-
lyzer (PPA) software (24).
Light-induced in Vivo Proteolysis of CRYs—HEK293T cells
(90% confluency) were transfected with 2 g of appropriate
plasmidDNAusing Lipofectamine 2000 reagent (Invitrogen) in
35-mmdishes. The cells were kept in the dark for 24 h and then
exposed to blue light at a fluence rate of 2milliwatts/cm2 for the
indicated periods (19). The extent of photoinduced proteolysis
was determined by Western blotting using the appropriate
antibodies, and the level of CRY proteolytic degradation was
quantified using the ImageQuant 5.0 (Molecular Dynamics)
software after scanning the immunoblots.
Checkpoint Response Assay—HEK293T cells (90% conflu-
ency) were transfected in 35-mm dishes using FuGENE HD
(Promega) and increasing amounts of plasmid DNA expressing
AtCRY2-GFP-TopBP1 fusions. Total transfected DNA was
maintained constant in each dish by the addition of pcDNA3.1
empty vector. After incubation for 18 h, cells were exposed to
blue light for 1 h and incubated for a further 1 h at 37 °C, and
then the cells were harvested and lysed, and cell lysates were
separated by SDS-PAGE. Chk1 phosphorylation was detected
by immunoblotting using Ser-345 phospho-ChK1 antibodies
(Cell Signaling), and the levels of total Chk1 protein were
subsequently detected by immunoblotting with anti-Chk1
antibodies (Santa Cruz Biotechnology) using the same mem-
brane. Levels of phosphorylation were quantified using the
ImageQuant 5.0 (Molecular Dynamics) software after scanning
the immunoblots. The highest level of Chk1 phosphorylation in
each experiment was set equal to 100, and the levels of phos-
phorylated Chk1 in the other lanes were determined relative to
this value. The averages from three independent experiments
were graphed, and the error bars in Figs. 2, 3, and 5 indicate the
S.D.
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RESULTS
Formation of Cryptochrome Photobodies in Mammalian
Cells—Although cryptochromes from plants, insects, and
mammals exhibit highly conserved structures, they play diverse
roles in light signal transduction pathways. Human cells pos-
sess cryptochromes 1 and 2, which are core circadian clock
proteins, but are not known to have a photosensory function;
they are not degraded following blue light exposure and are not
known to form photobodies (16, 19). In contrast, insect Type 1
CRYs including Drosophila CRY (DmCRY) and plant crypto-
chromes including AtCRY2 are degraded following blue light
exposure, andAtCRY2 forms photobodies prior to degradation
in plant cells (11, 19). We have previously shown that light-
induced DmCRY proteolysis does not require any Drosophila-
specific protein as it occurs when mammalian cells ectopically
expressingDmCRYare exposed to blue light (19).Wewished to
determine whether AtCRY2 would be similarly degraded by
blue light in mammalian cells and whether the degradation of
both DmCRY and AtCRY2 proceeds through a prerequisite
photobody formation as AtCRY2 does in plant cells.
To this end, we constructed plasmids expressing AtCRY2-
GFP, DmCRY-GFP, and mouse mCRY2-GFP fusion proteins
(Fig. 1A) and transfected human HEK293T cells with these
plasmids, which were then exposed to blue light and analyzed
by fluorescence microscopy. As shown in Fig. 1, B–D, both
AtCRY2-GFP and DmCRY-GFP are predominantly located in
the nucleus, and prior to blue light exposure, exhibit uniform
nuclear distribution. Similarly, mCRY2-GFP also appears to be
exclusively in the nuclei (Fig. 1C). Exposure to blue light does
not affect the nuclear localization patterns of DmCRY-GFP and
mCRY2-GFP. In contrast, AtCRY2-GFP forms distinct photo-
bodies following blue light exposure (Fig. 1B), quite similar to
photobodies that form in plant cells. Two conclusions emerge
from these findings. First, as evident from the behavior of
DmCRY, not all photosensory CRYsmake photobodies follow-
ing light exposure. Second, and of special relevance, AtCRY2
forms photobodies in mammalian cells much in the same way
as it does in plant cells, indicating that photobody formation
does not require any plant-specific protein other than crypto-
chrome itself.
Light-induced Proteolysis of AtCRY2 in Mammalian Cells—
As in all signal transduction systems, the phototransduction
signal must be eventually down-regulated to maintain the
organismic homeostasis. Photosignaling initiated by DmCRY,
as well as AtCRY2, is turned off by light-induced proteolysis of
these cryptochromes (15, 19). Previously, we showed that light
promotes DmCRY degradation in mammalian cells, indicating
that no specificDrosophila protein is required for DmCRYpro-
teolysis (19). We wished to find out whether AtCRY2 behaved
in a similar manner. HEK293T cells expressing either AtCRY2-
GFP or DmCRY-GFP were exposed to blue light for 1–4 h, and
the levels of these proteins were analyzed by immunoblotting.
As seen in Fig. 2A, both cryptochromes are degraded with sim-
ilar kinetics, whereas mouse CRY2, which is not known to be a
FIGURE 1. Effect of light on subnuclear distribution of Arabidopsis, Dro-
sophila, and mouse cryptochromes expressed in human cells. A, sche-
matic of the proteins used in this study. B–D, HEK293T cells were transfected
with the indicated expression vectors kept in the dark or exposed to blue
light, fixed, and visualized by DAPI staining and/or fluorescence microscopy.
Bar  5 m.
FIGURE 2. Properties of AtCRY2-GFP photobodies in human cells. A, deg-
radation of photosensory cryptochromes expressed in human cells by blue
light. HEK293T cells, which were transfected with vectors expressing -galac-
tosidase as a control together with AtCRY2-GFP or DmCRY-GFP, were sub-
jected to blue light irradiation for the indicated time periods and then ana-
lyzed by immunoblotting. Left panel, immunoblots. Right panel, quantitative
analysis of three experiments. Values were normalized to -galactosidase
levels (internal control). Error bars indicate S.E. B, stability of photobodies in
mammalian cells. HEK293T cells were transfected with AtCRY2-GFP and
exposed to blue light for the indicated periods of time followed by incubation
in dark for 60 (60’L:60’D), 120 (60’L:120’D), or 360 min (60’L:360’D) and visual-
ized by fluorescence microscopy (GFP) and DAPI staining. C, effect of AtCRY2
levels on photobody formation. Flp-In/FLAG-AtCRY2-EGFP cells were treated
with tetracycline (Tet) for the indicated periods of time. Top panel, a fraction of
the cells was harvested and analyzed by immunoblotting. Bottom panel, the
rest of the cells were exposed to blue light for 1 h, fixed, and visualized by
DAPI staining and fluorescence microscopy. The numbers in parentheses indi-
cate the percentage of cells that contained nuclear photobodies. These num-
bers were obtained from the lower magnification field (three left columns),
and the last column shows selected frames to illustrate photobody formation
under all three conditions. Bar  5 m.
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photosensory protein, is not affected under similar conditions
(19), indicating that the light-induced proteolysis of certain
cryptochromes represents a physiological step in their signaling
pathways and is not caused by nonspecific protein degradation
by toxic light doses. We also note that because DmCRY, which
does not form PBs, and the photobody-forming AtCRY2 are
both subject to light-induced proteolysis, these data indicate
that PB formation is not an essential step on the pathway to
proteolysis.
Kinetics of Formation and Resolution of AtCRY2 Photobodies—
In plant cells, AtCRY2-GFP photobodies form in a light-dose-
dependentmanner and gradually disappear upon transfer from
a light to a dark environment (1, 20–22). We wished to know
whether AtCRY2-GFP followed the same pattern in human
cells. As seen in Fig. 2B, after 30 min of light exposure, a sub-
stantial amount of AtCRY2-GFP is in photobodies under our
illumination conditions. After 60 min of blue light exposure,
the majority of AtCRY2-GFP is in photobodies. When cells
were then incubated in the dark, the number of photobodies
gradually decreased over the course of 6 h, as has been observed
in plant cells.
Because photobody formation entails clustering of the pho-
tosensory protein, and this process is expected to be dependent
on the amount of the photoreceptor, we next investigated the
effect of AtCRY2-GFP protein level on photobody formation.
Flp-In/FLAG-AtCRY2-EGFP cells stably expressing AtCRY2-
GFP under a tetracycline-on promoter were treated with tetra-
cycline for 12, 24, or 48 h and exposed to blue light for 1 h, and
then analyzed by immunoblotting for AtCRY2-GFP expression
and for photobody formation by fluorescence microscopy. As
seen in Fig. 2C, AtCRY2-GFP steadily increases over the course
of the experiment, and the number of photobody-positive cells
increases in parallel after blue light exposure. All these findings
suggest that AtCRY2-GFP follows the same path for photobody
formation in human cells as it does in plant cells.
Composition of AtCRY2 Photobodies in Mammalian Cells—
All NBs characterized to date contain many types of proteins,
up to 40 different proteins in PML-NBs (2, 3). However, in
general, the roles of the different types of proteins other than
the defining member (PML in case of PML-NBs) in NB forma-
tion and function are not known. A genetic screen inArabidop-
sis identified several proteins that were essential for phyto-
chrome B photobody formation (10). No such screen has been
reported for AtCRY2. However, it has been found that light
promotes binding of AtCRY2 to SPA1, which leads to forma-
tion of AtCRY2-SPA1-COP1 ternary complex and inhibition of
E3 ligase activity of COP1 on transcription factors leading to
the accumulation of these transcription factors and hence to
blue light-specific gene expression pattern and phenotype (11,
20–22). Humans do not possess an SPA1 homolog, and hence
the pathway operative in plant cells for AtCRY2-COP1 interac-
tion is not relevant in human cells. However, humans do have a
COP1 homolog (23), which could potentially directly interact
with AtCRY2. Thus, we wished to determine whether AtCRY2
interacted with human COP1 and whether this interaction was
affected by light. To this end, we analyzed the effect of AtCRY2
on the subcellular distribution of COP1 in HEK293T cells. The
cells were transfected with either mouse COP1-Cherry or
AtCRY2-GFP plasmids (Fig. 3A), alone or in combination, and
the cellular localizations of the two proteins before and after
blue light exposure were analyzed by fluorescence microscopy.
As seen in Fig. 3B, COP1 is uniformly distributed in the nucleus
and cytoplasm, and light exposure does not affect its distribu-
tion in the absence of AtCRY2. In contrast, AtCRY2-GFP,
which is uniformly distributed in the nucleus in the dark, forms
photobodies upon light exposure, as expected. Importantly, in
cells transfected with both plasmids, although in the dark both
COP1 and AtCRY2 exhibit distribution similar to that when
each protein is expressed alone, after light exposure most of
AtCRY2 and a significant fraction of COP1 are in nuclear bod-
ies and, within the resolution of our assay, all of the COP1
nuclear bodies overlap with AtCRY2 photobodies (Fig. 3C).
This is supported by the protein proximity index analysis (24),
FIGURE 3. Mouse COP1 co-localizes with AtCRY2 in photobodies formed
in human cells. A, schematic of the proteins used in this study. B and C,
HEK293T cells were co-transfected with AtCRY2-GFP and mCOP1-mCherry
expression vectors either individually (B) or in combination (C) and then
exposed to blue light where indicated and analyzed by DAPI staining and GFP
fluorescence. B, light induces formation of AtCRY2 photobodies but has no
effect on subnuclear distribution of COP1 when cells are transfected with the
individual expression vectors. C, when cells are co-transfected with AtCRY2-
GFP and COP1-mCherry, both AtCRY2 and COP1 make photobodies, and the
two photobodies overlap, indicating that AtCRY2 recruits COP1 to AtCRY2
photobodies. D, light stimulates binding of AtCRY2 to COP1. Flp-In/FLAG-
AtCRY2-EGFP were induced with tetracycline (Tet) for 48 h where indicated.
Cells were then irradiated with blue light (BL) for the indicated periods of time
and lysed, and AtCRY2 was immunoprecipitated with FLAG antibodies. The
immunoprecipitates (IP) were analyzed for AtCRY2 and COP1 by immuno-
blotting. The relative levels of COP1 in AtCRY2 immunoprecipitates were
quantified and plotted as shown in the right panel, and the bar graph shows
the average of three experiments  S.E. COP1 levels were normalized to the
AtCRY2 protein levels; normalized COP1 level at the 0-min time point was
given a value of 1. Bar  5 m.
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which yields a value of 0.8, consistent with co-localization.
Thus, it appears that even in the absence of SPA1, photoexcita-
tion of AtCRY2 promotes its interaction with COP1. Because it
has been reported that AtCRY2 interacts with COP1 only
through intermediacy of SPA1 (14), we decided to analyze the
AtCRY2-COP1 interaction identified by photobody analysis by
an additional method, using immunoprecipitation.
Flp-In/FLAG-AtCRY2-EGFP cells were induced with tetra-
cycline for 48 h, irradiated with blue light for 5–60 min, and
then lysed, AtCRY2 was immunoprecipitated, and the immu-
noprecipitate was analyzed for COP1 by immunoblotting. As
seen in Fig. 3D, AtCRY2 binds to COP1 even in the dark, and
importantly, this binding is stimulated by blue light by up to
2.5-fold. This finding suggests that light can stimulate direct
AtCRY2-COP1 interaction in the absence of SPA1. However,
the possibility that this interaction is aided by a human protein
that can substitute for SPA1 cannot be eliminated.
Specificity of Protein-Protein Interactions within AtCRY2
Photobodies—To ascertain that the AtCRY2-COP1 interaction
we observe in AtCRY2 photobodies represents light-promoted
specific protein-protein interactions and not blue light stress-
induced protein aggregation, we analyzed AtCRY2 photobod-
ies for PML protein because this protein has been implicated in
NBs that contribute to cellular responses to various stress con-
ditions (2, 3). PML-NBs are constitutively present in most
human cell lines including HEK293T, which was used in our
study. To address a potential role for PML in formation of
AtCRY2 PBs, HEK293T cells were transfected with AtCRY2-
GFP plasmids and either kept in the dark or exposed to blue
light and analyzed for AtCRY2 by immunofluorescence stain-
ing and for PML by immunohistochemical staining. The results
are shown in Fig. 4. In the dark, AtCRY2-GFP exhibits uniform
nuclear distribution as expected. In contrast, PML localizes to
nuclear bodies, consistent with its known properties. Upon
light exposure, AtCRY2-GFP forms nuclear bodies, and hence
the nuclei of these cells contain two types ofNBs, PML-NBs and
AtCRY2-PB. Merging of the two images by using protein prox-
imity index analysis (24) yields a value of 0.4, which indicates
that this overlap is within the limit of randomoverlap. Thus, we
conclude that theAtCRY2-PBs are specific structures that form
by light-induced association of AtCRY2 with itself and COP1
E3 ligase and represent a step on the AtCRY2 signaling
pathway.
Use of Photobodies to Regulate Intranuclear Signaling
Pathways—The sequestration of AtCRY2 by light in discreet
nuclear bodies raised the potential that this property of crypto-
chrome could be used to control certain signaling pathways by
light. Here, we attempted to initiate the ATR-mediated DNA
damage checkpoint signaling pathway by blue light in the
absence of DNA damage. ATR (ATM and Rad3-related) initi-
ates the DNA damage checkpoint response by phosphorylating
downstream targets in response to DNA damage by UV and
UV-mimetic agents (25). The TopBP1 protein, which contains
multiple BRCT domains that are involved in protein-protein
interactions, functions as an activator/mediator of ATR kinase
function (26, 27). Previously, it was shown that by fusing
TopBP1 to the Lac repressor and targeting it to an array of
tandem Lac operators stably inserted into the genome of
NIH3T3 cells, ATR kinase was activated in the absence of DNA
damage by sequestering it into a subnuclear region defined by
the tandem array of Lac operators (18). We reasoned that it
might be possible to activate the ATR kinase by sequestering
TopBP1 in the nucleus of mammalian cells in the form of
photobodies.
To establish a system in which the ATR-initiated checkpoint
is regulated by light, TopBP1 was fused to AtCRY2-GFP (Fig.
5A). HEK293T cells were transfected with this plasmid and
exposed to blue light to induce photobody formation. As in the
case of AtCRY2-GFP, the AtCRY2-GFP-TopBP1 fusion pro-
tein efficiently forms photobodies upon blue light exposure
(Fig. 5B). We hypothesized that the clustering of TopBP1
within these photobodies artificially increases the local concen-
tration of the checkpoint protein complex andmay activate the
DNA damage checkpoint in the absence of DNA damage. As a
readout, wemeasured the phosphorylation of Chk1 checkpoint
signaling kinase, a major target of ATR in DNA damage check-
point response (25). As seen in Fig. 5C, blue light alone, in the
absence of DNA damage, causes up to 5-fold increase in Chk1
phosphorylation in cells expressing AtCRY2-GFP-TopBP1 but
not in AtCRY2-GFP-expressing cells, indicating that AtCRY2-
mediated clustering of TopBP1 is sufficient to activate the
checkpoint response.
In conducting these experiments, we were concerned about
two potential sources of artifacts. First, it has been shown that
transfecting cells with high levels of TopBP1-expressing plas-
mid can activate ATR in the absence of DNA damage (18, 27).
Secondly, high doses of blue light could generate reactive oxy-
gen species from overexpressed flavoproteins, such as AtCRY2,
which could cause DNA damage and activate DNA damage
checkpoints (28). To address these potential problems, we car-
ried out two types of controls. First, we used high levels of
AtCRY2-GFP in transfection assays in parallel with the
AtCRY2-GFP-TopBP1 transfections. As seen in Fig. 5C, lanes 1
and 2, transfection with AtCRY2-GFP with and without light
exposure does not cause Chk1 phosphorylation. In contrast,
transfection with AtCRY2-GFP-TopBP1 induces Chk1 phos-
phorylation even with low level of DNA in the transfection
assay and in a manner that is strongly dependent upon blue
FIGURE 4. PML bodies do not co-localize with AtCRY2 photobodies in
human cells. HEK293T cells were transfected with AtCRY2-GFP, and 48 h
later, they were either kept in the dark or exposed to blue light for 1 h and
analyzed by immunofluorescence staining (GFP) or immunohistochemical
staining (PML). PML bodies are apparent in both dark and light samples,
whereas AtCRY2 is uniformly distributed in the nuclei of the dark samples and
forms nuclear bodies (photobodies) upon light exposure. The AtCRY2 photo-
bodies and PML-NBs do not overlap, indicating that PML is not required for
formation nor is it recruited to AtCRY2 photobodies. Bar  5 m.
Light-induced Photobody Formation and Checkpoint Control
23248 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 288 • NUMBER 32 • AUGUST 9, 2013
light exposure. At relatively high plasmid levels, some Chk1
phosphorylation is observed in the absence of light exposure
(Fig. 5C, lanes 7 and 9), in agreement with previous studies
indicating that high level expression of TopBP1 induces Chk1
phosphorylation (18, 27). However, even under these condi-
tions, light exposure increases Chk1 phosphorylationmarkedly
over the dark controls (compare lanes 7 and 8 with lanes 9 and
10). Secondly, to demonstrate that the blue light-induced
checkpoint activation was due to clustering of TopBP1 in pho-
tobodies, we used the mutated AtCRY2 (D387A) as a control.
The D387A mutation in the FAD binding pocket completely
eliminates FAD binding to AtCRY2 and photobody formation
(8). We constructed AtCRY2(D387A)-GFP-TopBP1 (Fig. 5D),
transfected HEK293T cells with this plasmid, exposed cells to
blue light, and examined photobody formation by immunoflu-
orescence and checkpoint activation by Western blotting
against Chk1 phosphorylation. The mutant protein, like wild
type, exhibits uniform nuclear localization in the dark control,
but in contrast to wild type, it does not form photobodies upon
blue light exposure (Fig. 5E) and does not activate Chk1 phos-
phorylation (Fig. 5F) in the absence or presence of blue light
(Fig. 5F, lanes 5 and 6) under conditions conducive to activation
by thewild type (Fig. 5F, lanes 3 and 4). Taken together, our data
lead us to conclude that by fusing theATR co-activatorTopBP1
to AtCRY2, we have developed a unique system of activating
the ATR-Chk1 checkpoint signaling pathway with blue light in
the absence of DNA damage.
DISCUSSION
In recent years, a number of methods have been developed
that use photosensory proteins for regulating biological func-
tions at the cellular and even organismal levels (29, 30). These
include channelopsin, which employs retinal phytochromes,
which employ a linear bilin, and LOV (light-oxygen-voltage-
sensing) domain proteins, which employ FMN as chro-
mophores. With all these systems, light-induced conforma-
tional changes in the photosensory protein itself, or in the
target protein such as Raf fused to the chromophore binding
module of the photosensory protein, initiate a chain of events
that leads to activation of a particular signal transduction path-
way or regulation of a specific biochemical network.
In addition to conformational change-induced regulation of
activity, light is also known to induce complex formation of two
plant photosensory proteins, the red light sensor phytochrome
and the blue light sensor cryptochrome with their effector tar-
get proteins (4, 11). In both cases, light also induced the forma-
tion of large protein aggregates (0.1–0.5 m in diameter),
which have many features in common with other nuclear bod-
ies, and because their formation is strictly light-dependent, they
have been named photobodies (4). Although it is unclear at
FIGURE 5. Activation of the ATR-Chk1 signaling pathway by photobody formation. A, schematic of the AtCRY2-GFP-TopBP1 construct. aa, amino acids. B,
formation of AtCRY2-GFP-TopBP1 photobodies probed by fluorescence microscopy imaging. C, in vivo checkpoint activation by AtCRY2-GFP-TopBP1.
HEK293T cells were transfected with either AtCRY2-GFP or increasing amounts of AtCRY2-GFP-TopBP1 plasmids (0.1, 0.25, and 0.5, 1 g) and kept in the dark
or exposed to blue light (BL) as indicated. Cell lysates were prepared, and the expression of AtCRY2-GFP, AtCRY2-GFP-TopBP1, and Chk1 as well as the level of
Ser-345 phospho-Chk1 (p-Chk1(Ser345)) were probed by Western blotting. The top panel shows a representative Western blot experiment; the bottom panel
shows quantitative analysis of Chk1 phosphorylation. Error bars indicate S.D. from three independent experiments. D, schematic of the fusion protein construct
AtCRY2(D387A)-GFP-TopBP1 with the AtCRY2 FAD binding site mutation. E, fluorescence microscopy imaging with AtCRY2(D387A)-GFP-TopBP1 mutant. F, in
vivo checkpoint assay with AtCRY2(D387A)-GFP-TopBP1 mutant. Top panel, Western blotting; bottom panel, quantitative analysis of Chk1 phosphorylation,
expressed relative to the highest level. HEK293T cells were transfected with AtCRY2(D387A)-GFP-TopBP1 plasmids (0.1 g) and kept in the dark or exposed to
blue light as indicated. Error bars indicate S.D. from three independent experiments. Bar  5 m.
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present whether photobody formation is an essential step on
the activation pathway of these photoreceptors, in both cases,
COP1 E3 ligase is associated with photobodies, and photobody
formation is followed by degradation of the photosensory pro-
tein by the proteasome. Hence, currently available evidence is
consistent with photobodies consisting of proteins in aggre-
gates destined for dismantling and thus the deactivation of the
light-activated signaling pathway. Formation of phytochrome
photobodies appears to depend on participation of several
other proteins, one ofwhich is a polyubiquitin-binding protein-
like protein, hemera (10). Whether or not cryptochrome pho-
tobody formation requires other proteins is not known. Previ-
ously, AtCRY2 was expressed in human cells, and upon blue
light excitation, it was shown to interact with the co-expressed
plant transcription factor, CIB1, in a manner similar to what is
observed during blue light signaling in Arabidopsis (31). How-
ever, in that study, neither the association of AtCRY2 with
endogenous human COP1 nor its proteolysis was investigated.
Here, we show 1) that AtCRY2 forms photobodies in the
nuclei of human cells, 2) that photobody formation is followed
by proteolysis, 3) that photobodies of AtCRY2 contain COP1 in
mammalian cells as observed in plant cells, and 4) importantly,
that by fusing AtCRY2 to a checkpoint protein, we can activate
the DNA damage checkpoint signaling pathway in the absence
of DNA damage. It is likely that recruitment of other check-
point proteins to TopBP1 leads to high local concentration of
ATR checkpoint complex in the photobodies, which is suffi-
cient to activate the downstream signaling events. Hence, it will
be informative to use our optogenetic system to quantitatively
study the ATR-mediated cell cycle checkpoints at high spatial
resolution in further studies.
We note that while this manuscript was in preparation,
another group reported AtCRY2 photobody formation in
human cells (32). In that study, AtCRY2 with a deletion of the
nuclear localization signal in the C-terminal extension of the
cryptochrome was used. As a result, cytoplasmic photobodies
were formed, and by fusing this form of AtCRY2 with the
appropriate proteins, specificmembrane/cytoplasmic signaling
pathways could be regulated. That study did not address the
issue of photobody composition or the issue of light-induced
proteolysis of AtCRY2 in mammalian cells. Nevertheless, tech-
nologically, the two studies are complementary in terms of one
providing a method for activation of intranuclear pathways
(this work) and the other providing a method for activation of
cytoplasmic/membrane-associated (32) signaling pathways by
light pulses. Because protein clustering regulates numerous sig-
naling pathways, light-induced AtCYR2 photobody will be a
powerful tool to study various cellular events.
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